http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103127125-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b1fbc33d49dafd622558b0c949e63e6
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
filingDate 2013-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6af0d386c07b115a3c05debea422c5f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5aad02153ef20fdb37d75360be14c8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_246589ca62a7bc64488a1dcd74bbc2ef
publicationDate 2014-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103127125-B
titleOfInvention Paracetamol and caffeine dry suspension and preparation method thereof
abstract The invention discloses a paracetamol and caffeine dry suspension and a preparation method of the paracetamol and caffeine dry suspension. The paracetamol and caffeine dry suspension comprises 40-100 parts of active ingredients, 600-2200 parts of filler, 50-200 parts of flavoring agents, 40-100 parts of suspending agents and 10-40 parts of flocculating agents, wherein the active ingredients are formed by acetaminophen and caffeine. The ratio of the acetaminophen to the caffeine is 1:0.13 by weight. The paracetamol and caffeine dry suspension is even in particle distribution, good in stability, large in distribution area in a stomach and intestines, quick in absorption, high in bioavailability, quick in effect producing, and superior to paracetamol and caffeine premixing agents in pharmaceutical effect.
priorityDate 2013-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410507375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442089
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134601
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420954282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452546156
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44263857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154497524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536614

Total number of triples: 42.